We propose that BV8 CD8+ T cells may play a role in the pathogenesis of this immunodeficiency syndrome.
Introduction
Thymomas are tumors of thymic epithelium characterized by severe alterations of the immune system not yet completely understood (1) (2) (3) (4) (5) (6) (7) (8) . A severe immunodeficiency with B-cell defect is found in a small percentage of thymoma patients (1) (2) (3) (4) (5) (6) , this condition is also known as Good's Syndrome (2) . The immunodeficiency may precede or follow thymectomy and B-cells are undetectable in the periphery (4, 9, 10) . The coexistence of autoimmunity and immunodeficiency causes life-threatening problems in the management of these patients (7) (8) (9) (10) .
The pathogenesis of B-cell loss represents a puzzling phenomenon, the understanding of which might help us to find a better approach to treat this syndrome. It has been documented that CD8+ T-lymphocytes derived from blood of patients with thymoma and immunodeficiency are able to suppress proliferation of allogeneic pre-B cells. Thus, it has been suggested that an aggression toward B cell precursors is responsible for the immunodeficiency (4-6). The Spectratyping analysis represents a novel tool to address this unresolved question (11) (12) (13) (14) (15) . Therefore, we examined the T cell repertoire of peripheral and bone marrow lymphocytes in five thymoma patients suffering from immunodeficiency and in seven control individuals. The absence of B lymphocytes was always characterized by the expansion of BV 8 positive T cells in the marrow. These data provide novel evidences for the involvement of CD8+ T cells in the pathogenesis of Good's Syndrome, supporting the idea that B cell loss is due to an aggression toward B cell precursors.
Study Design
The main characteristics of the patients included in this study are shown in table 1. Tumor hystology has been classified according to WHO proposal (16) . The majority of them received thymectomy and showed an inversion of the CD4+/CD8+ ratio. Five patients were suffering from severe immunodeficiency syndrome characterized by recurrent infections of the lower respiratory tract. Flow cytometry analyses were performed at monthly intervals in the last six months showing a stable reduction of mature CD19+ peripheral cells (Unique Patient Number, UPNs 091, 157, 051, 009, 147). A marked hypogammaglobulinemia had been detected in four out of five patients, while one of them has normal Ig serum levels (UPN 091). On the bases of clinical signs and B lymphopenia we classified these patients as suffering from Good's syndrome. We included in the study also two thymoma patients with normal Ig serum levels, normal B cell counts and no signs of severe recurrent infections (TC 011, TC 087). Three patients with thymoma unrelated diseases (SLE, Myelodysplasia, and Hystiocytosis, SLE 354, MD 27 and Hys 104 respectively) as well as two healthy donors (HC 1 and HC 2) were also For personal use only. on October 3, 2017. by guest www.bloodjournal.org From investigated. In the year before BM sampling patients 009 and 147 received Prednison and Cyclosporin.A. Treatments were suspended one month before bone marrow sampling. Thus, we considered all patients free of immunosuppressive treatment at the moment of this study. All subjects were fully informed about the aim of the research and agreed to donate samples. Marrow samples were obtained taking advantage of material used for diagnostic purposes. Morrow samples from two allogenic transplantation donors were used as controls (healthy controls: HC 1 and HC 2). The immunophenotype was done on whole blood by means of standard three-color flow cytometry. To perform the Spectratyping (11), T-cells were separated from blood and marrow by density gradient according to standard procedures (Lymphoprep, Oslo, Norway). When a sufficient amount of lymphocytes was available from marrow samples, T cells were separated in CD8+ and CD8-cells by magnetic sorting with coated beads (Dynabeads, Dynal, Oslo, Norway). RNA was prepared by Trizol (GIBCO-BRL,Bethesda, MD) according to the manufacturer's instructions. Reverse-transcription and PCR amplification for the 25 different beta variable TCR families (BV) was performed by the one-step PCR protocol (GIBCO-BRL, Bethesda, MD). To resolve the composition of each BV TCR family, the PCR products were run on a sequencing gel in fluorescence based DNA sequencer (11) (12) (13) . Normally, each TCR family is resolved by this technique as a series of bands having a gaussian distribution. Each alteration, in either the distribution or the intensity of single bands, represents a perturbation in the given BV-TCR family reflecting the involvement of that TCR BV family in an immune response toward one or more antigens (11) (12) (13) (14) (15) . PCR products corresponding to BV8
regions showing a single peak were separated on polyacrylamide gel. The major band was than cut from the gel, eluted and sequenced by direct PCR method (Big Dye Sequencing kit, V3.0, Applied Biosystem, Warrington, UK).
Results and Discussion
The immunophenotype analysis of peripheral lymphocytes derived from thymoma patients with immunodeficiency showed a stable decrease in the level of mature CD19+ (Tab. 1) and CD20+ B cells (data not shown). Unexpectedly, the BV 8 family showed a single-peak profile in bone marrow, but not in peripheral blood lymphocytes in five out of five Blymphopenic patients (Fig 1A) . We reasoned that these BV 8 families could share similarity in the CDR3 sequences, too. The direct sequencing analysis confirmed this hypothesis, revealing a conserved CDR3 motif (SF/LGXGXNXXQ/LH/Y) in all BV8 products found to be expanded (Fig 1B) . T cells isolated from marrow and blood samples of TC 087 patients and from the other control individuals expressed detectable amount of BV8 mRNA with a gaussian CDR3 profile (Fig. 1 C) . In the patient TC 011 we found only a barely detectable level of BV8 mRNA in marrow-derived lymphocytes (Fig. 1A) . In the figure 1D , we report a synopsis of the whole repertoire analysis expressed in CD8+ and CD8-T cells. A very limited number of altered For personal use only. on October 3, 2017. by guest www.bloodjournal.org From 5 families can be found in the marrows of B lymphopenic patients (Fig 1D) . Noteworthy, only BV8 families display a singlepeak profile. In two out of three patients BV8 have been found expanded only in CD8+ subset (UPN 091 and 157). In the individual 147, BV8 was expanded in CD8+ as well as in CD8-T cells. However, in this case the expression level was much higher in CD8+ than in CD8-lymphocytes (data not shown).
In conclusion, the whole body of data confirmed that bone marrow of B-lymphopenic thymoma patients was infiltrated by the oligoclonal expansion of CD8+ BV8+ T-lymphocytes. Since in the periphery BV8+ lymphocytes were normal, it was likely that the selective expansion detected in the marrow would results from an immune response toward an unknown pathogen (i.e. B lymphotropic virus) or from a direct autoimmune aggression against B-cell precursors. Autoimmune reaction against haematopoietic precursors seems to be responsible for disorders that are associated or not with thymoma (17) (18) (19) (20) . Clonal lymphocyte expansion has been found in the peripheral blood of patients with Pure Red Cells Aplasia (17) (18) (19) .
Furthermore, the analysis of the CDR3 size distribution in the bone marrow of patients with Aplastic Anemia indicates that an antigen-driven expansion of T cells is involved in the pathogenesis of this disease (20) . Our findings provide novel evidence supporting the hypothesis that a T cell-mediated reaction against haematopoietic precursors is responsible for the selective Bcell loss in a subgroup of thymoma patients. In light of this, the immunodeficiency with severe B lymphopenia syndrome associated with thymoma has to be included in the autoimmune phenomena occurring in the patients affected by this form of tumor. Further experiments are warranted to characterize the (auto)antigen(s) possibly involved in triggering this phenomenon. 
